Skip to main content
Article
Anti-CD45 radioimmunotherapy using 211At with bone marrow transplantation prolongs survival in a disseminated murine leukemia model
Blood (2013)
  • Johnnie J. Orozco, Fred Hutchinson Cancer Research Center
  • Tom Bäck, University of Gothenburg
  • Aimee Kenoyer, Fred Hutchinson Cancer Research Center
  • Ethan R. Balkin, University of Washington
  • Donald K. Hamlin, University of Washington
  • D. Scott Wilbur, University of Washington
  • Darrell R. Fisher, Pacific Northwest National Laboratory
  • Shani L. Frayo, Fred Hutchinson Cancer Research Center
  • Mark D. Hylarides, Fred Hutchinson Cancer Research Center
  • Damian J. Green, Fred Hutchinson Cancer Research Center
  • Ajay K. Gopal, Fred Hutchinson Cancer Research Center
  • Oliver W. Press, Fred Hutchinson Cancer Research Center
  • John M. Pagel, Fred Hutchinson Cancer Research Center
Publication Date
May 2, 2013
DOI
10.1182/blood-2012-11-467035
Citation Information
Johnnie J. Orozco, Tom Bäck, Aimee Kenoyer, Ethan R. Balkin, et al.. "Anti-CD45 radioimmunotherapy using 211At with bone marrow transplantation prolongs survival in a disseminated murine leukemia model" Blood Vol. 121 Iss. 18 (2013) p. 3759 - 3767
Available at: http://works.bepress.com/john-pagel/131/